News and Trends 11 Aug 2022 First patient enrolled on Panbela’s trial for treatment of pancreatic cancer …exacerbation of bone marrow suppression and peripheral neuropathy, which can be chemotherapy-related adverse events. Serious visual adverse events have been evaluated and patients with a history of retinopathy or at… August 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 May 2025 Nine promising small molecule drug discovery companies to look out for in 2025 …events reported as mild, and no severe or serious adverse events reported. Maze has raised a significant amount of money since it launched with $191 million in 2019; in 2022,… May 16, 2025 - 13 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Expert Advice 20 Mar 2023 Nine tips to succeed in pharma-biotech partnerships …and royalties. Attend biotech industry events to identify partnership opportunities Conferences can be one of the best ways to find potential partners, as they provide a platform for biotechs to… March 20, 2023 - 9 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jul 2024 German biotech raises $150M on its way to tackle cancer therapy resistance …events (TEAEs) being mild to moderate. Only a small percentage of patients experienced grade 3 or higher adverse events. Phil L’huillier, chief executive officer of CatalYm commented on these results…. July 16, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jun 2025 First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field? …ultimately necessary for the pathogen’s survival. By hindering the transport of these materials, such as lipopolysaccharide – which serves as the bacteria’s cell barrier – it prevents the formation of… June 9, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 23 May 2023 Vicore reports new data from idiopathic pulmonary fibrosis study …data show C21 continues to be safe and well tolerated with no treatment-related serious adverse events, and that C21 continues to demonstrate long-term efficacy. At 36 weeks the average forced… May 23, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Sponsored 20 Sep 2017 What you need to Know about the Legalization of Cannabis for Medical Use …a chain of unforeseeable events Germany has one of the strictest narcotic drugs laws in Europe. In my opinion, if the German Federal Administrative Court hadn’t made a very specific… September 20, 2017 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 21 Apr 2023 New discovery “an area of cancer research with tremendous promise for breakthroughs” …ANKLE1. ANKLE1 acts on chromatin bridges trapped in the midzone of dividing cells. By cutting these bridges, ANKLE1 prevents damage to the genetic material and stops the immune system from… April 21, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2024 Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it …tau pathology is OGA inhibition, which leads to the modification of individual tau proteins and prevents their incorporation into aggregates. OGA inhibition works inside cells to prevent the removal of… July 17, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Mar 2024 From LSD to healing minds: Where are we standing in psychedelic drug development? …2 safety data from its first clinical trial of psilocybin in treating PTSD, showing that their candidate, COMP360, was well-tolerated with no serious adverse events. This trial is part of… March 13, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2022 Hemophilia drug from Sanofi and Sobi has license application accepted for priority review by FDA …was well-tolerated, and inhibitor development to factor VIII was not detected. The most common treatment-emergent adverse events which was less than 5% of participants overall were headache, arthralgia, fall, and… August 30, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2022 Amolyt Pharma publishes hypoparathyroidism treatment results …the findings in bone biomarkers, bone mineral density (BMD) was stable, including in patients with osteopenia. AZP-3601 was well tolerated with no serious adverse events. There were only mild to… October 12, 2022 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email